(Q28237152)

English

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

scientific article (publication date: September 2011)

In more languages

Statements

scholarly article

0 references

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis (English)

0 references

ascending cholangitis

0 references

0 references

ulcerative colitis

1 reference

based on heuristic

inferred from title

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

primary sclerosing cholangitis

1 reference

based on heuristic

inferred from title

Kris V. Kowdley

5

object named as

Kris V Kowdley

0 references

Emmanouil Sinakos

4

object named as

Emmanouil Sinakos

0 references

author name string

John E Eaton

1

0 references

Marina G Silveira

2

0 references

Darrell S Pardi

3

0 references

Velimir A C Luketic

6

0 references

M Edwyn Harrison

7

0 references

Timothy McCashland

8

0 references

Alex S Befeler

9

0 references

Denise Harnois

10

0 references

Roberta Jorgensen

11

0 references

Jan Petz

12

0 references

Keith D Lindor

13

0 references

language of work or name

0 references

publication date

September 2011

0 references

The American Journal of Gastroenterology

0 references

106

0 references

9

0 references

1638-45

0 references

Bile acids as endogenous etiologic agents in gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

20 March 2017

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

20 March 2017

Conversion of 7-ketolithocholic acid to ursodeoxycholic acid by human intestinal anaerobic microorganisms: Interchangeability of chenodeoxycholic acid and ursodeoxycholic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

20 March 2017

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Bile acids as carcinogens in human gastrointestinal cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Cancer risk in patients with inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Role of bile acids in colorectal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

29 September 2017

Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

2 June 2018

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

2 June 2018

Diagnosis and management of primary sclerosing cholangitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Effects of diet on the fecal excretion and bacterial modification of acidic and neutral steroids, and implications for colon carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3168684

27 November 2018

Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fate of low grade dysplasia in ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of ursodeoxycholic acid in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Requirements for induction of DNA strand breaks by lithocholic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21556038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2011.156

0 references

release_zin4w4w2bzbu5gpx2qjiya75wm

1 reference

https://api.fatcat.wiki/v0/release/zin4w4w2bzbu5gpx2qjiya75wm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28237152&oldid=1879136492"